-
EP1446007
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1446007
| EP1446007 - METHODS AND COMPOSITIONS FOR TARGETING UNDERGLYCOSYLATED PROTEINS ACROSS THE BLOOD BRAIN BARRIER [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 22.06.2012 Database last updated on 12.06.2024 | Most recent event Tooltip | 22.06.2012 | Application deemed to be withdrawn | published on 25.07.2012 [2012/30] | Applicant(s) | For all designated states BioMarin Pharmaceutical Inc. 105 Digital Drive Novato, CA 94949 / US | [N/P] |
| Former [2011/20] | For all designated states BioMarin Pharmaceutical Inc. 105 Digital Drive Novato, CA 94949 / US | ||
| Former [2005/11] | For all designated states ZyStor Therapeutics, Inc. 770 North Water Street Milwaukee, Wisconsin, 53202 / US | ||
| Former [2004/34] | For all designated states Symbiontics, Inc. 4041 Forest Park Avenue St. Louis, MO 63108-2211 / US | Inventor(s) | 01 /
Dr Jonathan LeBowitz 6128 North Kent Avenue Whitefish Bay, WI 53217 / US | 02 /
SLY, Wilian, S. 7054 Westmoreland Drive St. Louis, MO 63130 / US | [2006/25] |
| Former [2006/23] | 01 /
LEBOWITZ, Jonathan, H. 6128 North Kent Avenue Whitefish Bay, WI 53217 / US | ||
| 02 /
SLY, Wilian, S. 7054 Westmoreland Drive St. Louis, MO 63130 / US | |||
| Former [2004/34] | 01 /
LEBOWITZ, Jonathan, H. 1 Devondale Lane St. Louis, MO 63131 / US | ||
| 02 /
SLY, Wilian, S. 7054 Westmoreland Drive St. Louis, MO 63130 / US | Representative(s) | Chapman, Paul William Kilburn & Strode LLP 20 Red Lion Street London WC1R 4PJ / GB | [N/P] |
| Former [2004/34] | Chapman, Paul William Kilburn & Strode, 20 Red Lion Street London WC1R 4PJ / GB | Application number, filing date | 02801739.0 | 16.10.2002 | [2004/34] | WO2002US32968 | Priority number, date | US20010329650P | 16.10.2001 Original published format: US 329650 P | US20020136841 | 30.04.2002 Original published format: US 136841 | US20020136639 | 30.04.2002 Original published format: US 136639 | US20020384452P | 29.05.2002 Original published format: US 384452 P | US20020386019P | 05.06.2002 Original published format: US 386019 P | US20020408816P | 06.09.2002 Original published format: US 408816 P | [2004/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO03032727 | Date: | 24.04.2003 | Language: | EN | [2003/17] | Type: | A1 Application with search report | No.: | EP1446007 | Date: | 18.08.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.04.2003 takes the place of the publication of the European patent application. | [2004/34] | Search report(s) | International search report - published on: | US | 24.04.2003 | (Supplementary) European search report - dispatched on: | EP | 24.10.2005 | Classification | IPC: | A01N37/18, A61K38/00, C12P21/06, C12N5/00, C12N5/02, C12N15/74, C07K1/00, C07K14/00, C07K16/00, C07K17/00, C07H21/04 | [2004/34] | CPC: |
C12N15/62 (EP);
A61K38/30 (EP);
A61K47/642 (EP);
A61K47/6425 (EP);
A61P13/12 (EP);
A61P25/00 (EP);
A61P9/10 (EP);
C07K14/65 (EP);
C07K2319/00 (EP);
C07K2319/02 (EP);
C07K2319/06 (EP);
C07K2319/21 (EP);
C07K2319/50 (EP);
C07K2319/61 (EP);
C07K2319/74 (EP);
C07K2319/75 (EP)
(-)
| C-Set: |
A61K38/30, A61K2300/00 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SK, TR [2004/34] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | VERFAHREN UND ZUSAMMENSETZUNG FÜR DIE ZIELSTEUERUNG VON HYPOGLYCOSYLIERTEN PROTEINEN ÜBER DIE BLUT-HIRN-BARRIERE | [2004/34] | English: | METHODS AND COMPOSITIONS FOR TARGETING UNDERGLYCOSYLATED PROTEINS ACROSS THE BLOOD BRAIN BARRIER | [2004/34] | French: | TECHNIQUES ET COMPOSITIONS PERMETTANT LE CIBLAGE DE PROTEINES SOUS-GLYCOSYLEES A TRAVERS LA BARRIERE HEMATO-ENCEPHALIQUE | [2004/34] | Entry into regional phase | 14.05.2004 | National basic fee paid | 14.05.2004 | Search fee paid | 14.05.2004 | Designation fee(s) paid | 14.05.2004 | Examination fee paid | Examination procedure | 13.05.2004 | Amendment by applicant (claims and/or description) | 14.05.2004 | Examination requested [2004/34] | 22.03.2006 | Despatch of a communication from the examining division (Time limit: M08) | 14.03.2007 | Reply to a communication from the examining division | 23.04.2007 | Despatch of a communication from the examining division (Time limit: M08) | 17.04.2008 | Reply to a communication from the examining division | 05.11.2008 | Despatch of a communication from the examining division (Time limit: M08) | 21.10.2009 | Reply to a communication from the examining division | 25.06.2010 | Despatch of a communication from the examining division (Time limit: M06) | 24.12.2010 | Reply to a communication from the examining division | 01.09.2011 | Despatch of a communication from the examining division (Time limit: M04) | 12.01.2012 | Application deemed to be withdrawn, date of legal effect [2012/30] | 28.02.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2012/30] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 22.03.2006 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 18.04.2008 | Request for further processing filed | 18.04.2008 | Full payment received (date of receipt of payment) Request granted | 26.05.2008 | Decision despatched | 14.03.2007 | Request for further processing filed | 15.03.2007 | Full payment received (date of receipt of payment) Request granted | 29.03.2007 | Decision despatched | Fees paid | Renewal fee | 25.10.2004 | Renewal fee patent year 03 | 27.10.2005 | Renewal fee patent year 04 | 27.10.2006 | Renewal fee patent year 05 | 29.10.2007 | Renewal fee patent year 06 | 27.10.2008 | Renewal fee patent year 07 | 26.10.2009 | Renewal fee patent year 08 | 25.10.2010 | Renewal fee patent year 09 | 25.10.2011 | Renewal fee patent year 10 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO9104014 (SYNERGEN INC [US]) [X] 1 * page 5, paragraph 2; claims 1,2 *; | [X]WO9502421 (ALKERMES INC [US], et al) [X] 1-30 * page 10, line 12 - line 29; claims 1-3,6 *; | [E]WO02087510 (SYMBIONTICS INC [US]) [E] 1* claims 1-52 *; | [E]WO03032913 (SYMBIONTICS INC [US], et al) [E] 1 * claims 1-20 *; | [E]WO03102583 (SYMBIONTICS INC [US], et al) [E] 1 * claims 1,10,11 * | International search | [Y]US6472140 (TANZI RUDOLPH E [US], et al); | [Y] - KIM S-O, "High-level expression and simple purification of recombinant human insulin-like growth factor I", JOURNAL OF BIOTECHNOLOGY, (199602), vol. 48, pages 97 - 105, XP002169455 DOI: http://dx.doi.org/10.1016/0168-1656(96)01402-2 | Examination | - DUFFY K R ET AL, "Human blood-brain barrier insulin-like growth factor receptor", METABOLISM, CLINICAL AND EXPERIMENTAL, W.B. SAUNDERS CO., PHILADELPHIA, PA, US, vol. 37, no. 2, ISSN 0026-0495, (19880201), pages 136 - 140, (19880201), XP026359542 |